Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATryn PK in Neonates on ECMO
NCT01913444Phase 4Withdrawn
- Sponsor
- Children's Hospital Los Angeles
- Start
- Jul 2013
- Primary completion
- Oct 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of antithrombin III in antithrombin III deficiency, sponsored by Children's Hospital Los Angeles. Planned start Jul 2013; status: withdrawn.
02
Drugs
antithrombin III
03
Conditions
antithrombin III deficiency
Beyond the preview
Go deeper on NCT01913444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01913444.